What to do when medication is impacting a claimant's cognition
Assessing medication-induced cognitive impairment and optimizing treatment
Published: 3 April 2026 | Updated: 3 April 2026
The problem
A claimant was injured and prescribed medication to manage pain or other injury consequences. Their physical recovery is progressing, but their treating team or family reports cognitive changes: slower thinking, difficulty concentrating, memory problems, confusion, or general mental fog. The claimant notices it too. They report feeling "not themselves." Questions arise: is the medication causing this? Is it a consequence of the injury itself? And if medication is the culprit, what's your responsibility to address it?
Medication-induced cognitive impairment is serious. It blocks rehabilitation, impairs judgment, and undermines recovery. If your funded medication is causing it, you have responsibility to act.
Which medications commonly cause cognitive effects?
Many medication classes can impair cognition. Common culprits in injury claims include:
- Sedating antihistamines: Older antihistamines (promethazine, doxylamine) cause drowsiness and cognitive slowing
- Benzodiazepines: Profound cognitive dulling, memory impairment, slowed processing, and dependence
- Opioids: Dose-dependent cognitive effects; sedation, memory impairment, and confusion common with high doses or long-term use
- Anticholinergics: Confusion, memory impairment, disorientation; particularly problematic in older adults
- Anticonvulsants: Many cause cognitive dulling; topiramate, levetiracetam, and phenytoin are particularly known for this
- Muscle relaxants: Sedation and cognitive dulling are common, especially with cyclobenzaprine
- Tricyclic antidepressants: Anticholinergic effects can impair cognition
- Corticosteroids: Mood and cognitive changes, particularly at high doses or with long-term use
- Combination therapy: Multiple CNS depressants together amplify cognitive effects dramatically
If the claimant is on any of these medications, particularly in combination or at high doses, medication-induced cognition is plausible.
Important distinction: Cognitive impairment can result from the injury itself (traumatic brain injury causes cognitive deficits) or from the medications used to treat injury consequences. Your job is to distinguish between these so you know what action to take.
Assessment: is this medication-induced or injury-related?
1. Establish the timeline of cognitive change
When did cognitive symptoms start? Did they appear after medication initiation or dose increase? If cognitive decline coincided with starting a CNS-depressant medication, medication causation is more likely. If cognitive problems were present since the injury and are not changing, they're likely injury-related, not medication-related.
2. Assess baseline cognitive function before injury
What was the claimant's cognitive function before the injury? Were they sharp, engaged, quick? Or did they have pre-existing cognitive limitations? This context matters. A claimant with pre-existing cognitive vulnerability is more susceptible to medication effects. Also, ask whether cognitive problems are typical for them or unusual.
3. Request objective cognitive testing
Don't rely on subjective reports alone. Request formal neuropsychological or cognitive testing from a neuropsychologist or appropriate clinician. Objective measures (memory tests, processing speed tests, executive function tests) provide evidence of impairment and can track changes over time. A single baseline test before medication change, then a repeat test after, can document whether cognition deteriorated coinciding with medication start.
4. Review the medication list for CNS-active drugs and interactions
Is the claimant on multiple CNS depressants? Benzodiazepines plus opioids plus muscle relaxant plus sedating antihistamine? This combination creates compounded cognitive effects. Even single agents at high doses can cause problems. Document the specific medications and their doses.
5. Assess whether cognition improves when medication is ceased or reduced
This is strong evidence. If cognitive symptoms improve within days or weeks of stopping or reducing a medication, that's powerful evidence the medication caused the problem. Request documentation of any medication changes and concurrent cognitive response. Does reduced medication dose bring cognitive improvement?
6. Rule out other causes of cognitive change
Cognitive impairment can result from infection, sleep deprivation, dehydration, electrolyte imbalance, thyroid dysfunction, depression, anxiety, or delirium. Has the claimant been medically evaluated for these? Medication is one cause among many. Comprehensive assessment should address alternatives.
Your action options
Option 1: Dose reduction
When to use: Medication is necessary and helpful, but current dose is causing cognitive effects.
Request the prescriber consider reducing the dose. Many cognitive effects are dose-dependent. Lower doses may preserve benefit while reducing cognitive impact. Titration can be slow (a few weeks to weeks of adjustment) to assess whether lower doses still provide adequate pain control or other benefits while preserving cognition.
Option 2: Switch to alternative medication with lower cognitive risk
When to use: The medication class is appropriate, but this specific medication is highly cognition-impairing.
Within medication classes, cognition impairment varies. Benzodiazepines differ in their cognitive effects. Opioids differ. Some anticonvulsants are more cognition-impairing than others. Switching to an alternative that provides similar benefit with lower cognitive risk is an option. Coordinate with the prescriber to make an informed switch.
Option 3: Deprescribe and transition to non-pharmacological approaches
When to use: The medication is causing cognitive impairment and alternatives aren't working.
For some claimants, the trade-off between medication benefit and cognitive cost isn't worth it. Deprescribing (with appropriate tapering if needed) and transitioning to psychological approaches, physical rehabilitation, or non-pharmacological pain management may be better. This requires clear planning and coordination, but sometimes it's the right call.
Option 4: Add medication to mitigate cognitive effects (cautiously)
When to use: Rarely, and only when other options aren't viable.
Theoretically, medications could be added to counteract cognitive effects (stimulants to counteract sedation, for example). This is generally not recommended because it adds medication and complexity. But in rare cases, when the underlying medication is essential and cognitive effects are significant, it might be considered. Use only with specialist input.
Practical scenarios
Scenario A: Benzodiazepine-induced cognitive dulling
A claimant is on long-term benzodiazepines for anxiety. They report memory problems and "fogginess." Cognitive testing shows impairment in memory and processing speed. These tests improve 2-3 weeks after benzodiazepine dose is reduced.
Your action: The benzodiazepine is causing the cognitive impairment. Initiate structured deprescribing with support (psychological therapy for anxiety, possibly an SSRI). If deprescribing isn't acceptable, pursue aggressive dose reduction. Fund rehabilitation-focused cognitive or occupational therapy to maximize function despite any remaining medication-related effects.
Scenario B: Opioid-induced cognitive dulling
A claimant on high-dose opioids for pain management reports difficulty thinking and concentrating. Pain control is good, but cognition is affected. They're struggling to engage in rehabilitation.
Your action: Collaborate with pain specialist to reduce opioid dose while adding alternative pain management (NSAIDs, topical agents, psychological pain management). Often, dose reduction preserves pain control while improving cognition. The claimant can then engage more fully in rehabilitation.
Scenario C: Polypharmacy-induced cognitive impairment
A claimant is on benzodiazepine, opioid, muscle relaxant, and anticholinergic antihistamine for various reasons. They're profoundly confused and disoriented. Each medication alone might be tolerable; together, they create severe cognitive impairment.
Your action: This requires a full medication review. Likely, not all of these medications are necessary or optimized. A pharmacist can identify redundancy, reduce or cease non-essential medications, and streamline the regimen to essential agents only at lower doses. Often, substantial deprescribing is needed.
Scenario D: Anticonvulsant-induced cognitive effects
A claimant on topiramate for migraine prophylaxis (which developed post-TBI) reports cognitive slowing and difficulty finding words. This is a known effect of topiramate.
Your action: Discuss with the prescriber whether alternative anticonvulsants (levetiracetam, gabapentin) or non-anticonvulsant alternatives (propranolol, amitriptyline) would be effective. If topiramate is essential, consider dose reduction or adding cognitive rehabilitation. Ensure the cognitive benefit of headache prevention justifies the cognitive cost of the medication.
Role of neuropsychological assessment
When medication-induced cognitive impairment is suspected, a neuropsychologist can:
- Establish baseline cognitive function
- Identify specific cognitive domains affected (memory, processing speed, attention, executive function)
- Track changes over time as medications are modified
- Distinguish medication effects from injury-related cognitive deficits
- Provide recommendations for cognitive rehabilitation or accommodation
This is valuable when causation is unclear or when you want objective documentation of cognitive change related to medication.
When to refer for a medication review
Refer for a pharmacist review when:
- Cognitive impairment is documented and medication causation is suspected
- The claimant is on multiple CNS-active medications
- You want optimization recommendations that minimize cognitive effects
- Deprescribing is being considered
- You need documentation of medication contribution to cognitive impairment
Documentation
Document:
- Timeline of cognitive change relative to medication initiation or dose changes
- Baseline cognitive function (if known)
- Current cognitive symptoms reported by claimant or observed by care team
- Results of any objective cognitive testing
- Current medication list with doses
- Any medication changes made and concurrent cognitive response
- Recommendations for medication optimization
- Actions taken to address medication-induced cognition
| Cognitive Finding | Likely Medication Class | Suggested Action |
|---|---|---|
| Sedation and memory impairment coinciding with benzodiazepine start | Benzodiazepine | Reduce dose or initiate deprescribing |
| Confusion and disorientation with multiple CNS depressants | Polypharmacy (opioid + benzo + muscle relaxant + anticholinergic) | Full medication review; substantial deprescribing likely needed |
| Processing speed slowing with anticonvulsant | Anticonvulsant (topiramate, levetiracetam) | Consider alternative anticonvulsant or non-anticonvulsant |
| Mild cognitive dulling at high opioid dose; improves with dose reduction | Opioid | Reduce dose while adding alternative pain management |
Key takeaways
- Medication-induced cognitive impairment is real and often preventable with optimization
- Establish temporal relationship between medication and cognitive change
- Use objective cognitive testing to document impairment and track changes
- Address polypharmacy; CNS depressants in combination have compounded effects
- Prioritize dose reduction or medication switching over accepting ongoing cognitive impairment
- Consider deprescribing and transition to non-pharmacological approaches when appropriate
- Refer for medication review when causation is unclear or optimization is complex
- Act urgently; cognitive impairment blocks rehabilitation and undermines recovery
Medications impairing your claimant's cognition?
IMM's pharmacists identify medication-induced cognitive effects, recommend optimization strategies, and coordinate with prescribers to preserve medication benefits while protecting cognition. We help claimants recover mentally, not just physically.
Request a Medication Review
